ArticlebioRxiv : the preprint server for biology2025
Mechanisms Driving Thoracic Aortic Aneurysm Stability.
Article in bioRxiv : the preprint server for biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
- Updated by
Authors and funding
5 authors.
Funding
Abstract
Thoracic aortic aneurysms (TAAs) arise from a combination of biological and mechanical factors. Current clinical guidelines use size and rate of expansion to stratify risk, but such metrics do not predict if an aneurysm will stabilize, grow, dissect, or rupture. Computational biomechanical models can provide insights into mechanisms of aneurysm behavior that would be difficult or impossible to capture in vivo. Here, we use a constrained mixture theory of growth and remodeling to simulate lesion progression while co-varying rate-dependent parameters that contribute to the natural history of aneurysm growth. This includes insults to the material structure and mechanosensitivity of the vessel. This framework successfully simulates clinically-relevant phenotypes, including cases where lesions with initially similar degrees of dilatation or rates of expansion diverge in behavior later in their progression. By capturing this spectrum of outcomes, our framework lays a foundation for more accurate, patient-specific risk prediction and future integration of machine learning tools to accelerate translation into clinical practice.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.